Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

40.79

+0.14 (0.34%)

At close: Apr 10, 2026, 4:00 PM EDT

40.77

-0.02 (-0.05%)

After-hours: Apr 10, 2026, 6:47 PM EDT

Apellis Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	5,215	3,181	3,973	7,157	5,728	4,611
Market Cap Growth	74.64%	-19.93%	-44.49%	24.94%	24.23%	5.88%
Enterprise Value	5,221	2,726	3,665	6,910	5,283	4,116
Last Close Price	40.79	25.12	31.91	59.86	51.71	47.28
PE Ratio	236.59	125.60	-19.94	-13.45	-8.41	-5.35
PS Ratio	5.20	3.17	5.08	18.05	75.95	69.27
PB Ratio	13.95	8.59	17.38	36.79	33.72	23.21
P/TBV Ratio	14.11	8.81	17.30	36.52	32.30	20.09
P/FCF Ratio	115.85	70.66	-45.01	-12.02	-11.12	-8.17
P/OCF Ratio	115.05	70.17	-45.21	-12.03	-11.15	-8.19
EV/Sales Ratio	5.20	2.72	4.69	17.42	70.05	61.84
EV/EBITDA Ratio	91.62	47.84	-22.46	-13.41	-8.91	-7.70
EV/EBIT Ratio	94.20	49.19	-22.21	-13.36	-8.89	-7.68
EV/FCF Ratio	115.99	60.57	-41.52	-11.60	-10.25	-7.30
Debt / Equity Ratio	0.03	0.03	0.45	0.54	0.63	1.04
Debt / EBITDA Ratio	0.33	0.33	-0.68	-0.21	-0.19	-0.39
Debt / FCF Ratio	0.42	0.42	-1.25	-0.19	-0.22	-0.37
Net Debt / Equity Ratio	-1.21	-1.21	-1.32	-1.24	-2.58	-2.47
Net Debt / EBITDA Ratio	-7.85	-7.85	1.85	0.47	0.74	0.92
Net Debt / FCF Ratio	-9.93	-9.93	3.41	0.40	0.85	0.87
Asset Turnover	1.02	1.02	0.93	0.51	0.09	0.07
Inventory Turnover	0.91	0.91	1.03	0.50	0.11	0.02
Quick Ratio	2.57	2.57	3.65	2.25	3.34	5.39
Current Ratio	3.14	3.14	4.25	3.10	4.29	6.25
Return on Equity (ROE)	53.36%	7.48%	-93.55%	-290.14%	-353.93%	-370.20%
Return on Assets (ROA)	5.25%	5.25%	-19.83%	-67.04%	-72.50%	-58.24%
Return on Invested Capital (ROIC)	15.12%	15.11%	-58.51%	-298.26%	-868.93%	-4551.49%
Return on Capital Employed (ROCE)	7.64%	7.64%	-26.60%	-91.22%	-88.58%	-67.79%
Earnings Yield	0.43%	0.80%	-5.01%	-7.43%	-11.89%	-18.70%
FCF Yield	0.86%	1.42%	-2.22%	-8.32%	-9.00%	-12.24%
Buyback Yield / Dilution	-4.80%	-4.80%	-4.40%	-11.84%	-25.70%	-12.32%
Total Shareholder Return	-4.80%	-4.80%	-4.40%	-11.84%	-25.70%	-12.32%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q